Sonoma Pharmaceuticals (SNOA) Earnings Date, Estimates & Call Transcripts $3.40 +0.61 (+21.86%) Closing price 03/11/2025 04:00 PM EasternExtended Trading$3.48 +0.08 (+2.21%) As of 03/11/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Sonoma Pharmaceuticals Latest Earnings SummaryLatest Q3 2025 Earnings DateFeb. 5EstimatedActual EPS (Feb. 5) -$0.59 Missed By -$0.59 Sonoma Pharmaceuticals issued Q3 2025 earnings on February 5, 2025, reporting an EPS of -$0.59. With a trailing EPS of -$4.02, Sonoma Pharmaceuticals' earnings are expected to decrease next year, from ($0.67) to ($1.79) per share. Get Sonoma Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sonoma Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSNOA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SNOA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Sonoma Pharmaceuticals Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.67) EPSNext Year EPS Consensus Estimate: ($1.79) EPS Remove Ads Sonoma Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails2/5/2025Q3 2025--$0.59 -$0.59-$0.63--11/7/2024---$0.59 -$0.59-$0.59-$3.58M8/8/2024--$0.06-$0.07 -$0.01-$0.07-$3.39M6/17/2024Q4 2024--$0.07 -$0.07-$0.07-$3.44M2/8/2024Q4 2023-$0.21-$0.06+$0.15-$0.04-$3.14M11/13/2023Q3 2023-$0.19-$0.20 -$0.01-$0.11-$2.73M8/10/2023Q1 2024--$0.29 -$0.29-$0.29-$3.43M6/21/2023Q4 2023--$0.23 -$0.23-$0.15-$3.01M Sonoma Pharmaceuticals Earnings - Frequently Asked Questions When did Sonoma Pharmaceuticals announce their last quarterly earnings? Sonoma Pharmaceuticals (NASDAQ:SNOA) last announced its quarterly earning data on Wednesday, February 5, 2025. Learn more on SNOA's earnings history. How much revenue does Sonoma Pharmaceuticals generate each year? Sonoma Pharmaceuticals (NASDAQ:SNOA) has a recorded annual revenue of $13.97 million. How much profit does Sonoma Pharmaceuticals generate each year? Sonoma Pharmaceuticals (NASDAQ:SNOA) has a recorded net income of -$4.84 million. SNOA has generated -$4.02 earnings per share over the last four quarters. What is Sonoma Pharmaceuticals's EPS forecast for next year? Sonoma Pharmaceuticals's earnings are expected to decrease from ($0.67) per share to ($1.79) per share in the next year. More Earnings Resources from MarketBeat Related Companies CTXR Earnings Date CHRO Earnings Date CRVO Earnings Date BMRA Earnings Date CLRB Earnings Date CING Earnings Date IMNN Earnings Date TRIB Earnings Date APRE Earnings Date ONVO Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles These 3 Q1 Earnings Winners Will Go HigherAnalysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of EarningsThe Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before Earnings Remove Ads This page (NASDAQ:SNOA) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredJeff Brown's Urgent March 17th AlertElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonoma Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonoma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
